11/22
02:11 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
Low
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
11/18
08:00 am
acxp
Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
Low
Report
Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
11/15
07:05 pm
acxp
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television [Yahoo! Finance]
Medium
Report
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television [Yahoo! Finance]
11/12
07:21 am
acxp
Acurx Pharmaceuticals GAAP EPS of -$1.23 beats by $0.05 [Seeking Alpha]
High
Report
Acurx Pharmaceuticals GAAP EPS of -$1.23 beats by $0.05 [Seeking Alpha]
11/12
07:01 am
acxp
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
High
Report
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
11/10
08:43 am
acxp
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens [Yahoo! Finance]
High
Report
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens [Yahoo! Finance]
11/10
08:00 am
acxp
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
Medium
Report
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
10/28
08:00 am
acxp
Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
Medium
Report
Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
10/27
08:00 am
acxp
Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update
Medium
Report
Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update
10/19
01:05 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S
Low
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S
10/11
01:09 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
Medium
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
10/9
07:30 am
acxp
Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
Medium
Report
Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
10/4
12:07 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S
Medium
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S
10/3
02:37 pm
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
9/30
11:26 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Low
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
9/30
07:55 am
acxp
Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection [Yahoo! Finance]
Low
Report
Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection [Yahoo! Finance]
9/30
07:30 am
acxp
Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection
Medium
Report
Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection
9/21
03:22 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
Low
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
9/13
01:07 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S
Medium
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S
9/6
10:34 am
acxp
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events [Yahoo! Finance]
Low
Report
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events [Yahoo! Finance]